Literature DB >> 13403531

Cortisone-thyroid therapy of metastatic mammary cancer.

H M LEMON.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/therapy; CORTISONE/therapeutic use; THYROID GLAND/extracts

Mesh：

Substances：

Year:  1957        PMID： 13403531     DOI： 10.7326/0003-4819-46-3-457

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Hypophysectomy in the treatment of breast cancer.

Authors:  A G JESSIMAN
Journal:  Ann R Coll Surg Engl       Date:  1959-04       Impact factor: 1.891

2.  Urinary gonadotrophin excretion in patients with ulcerative colitis and Crohn's disease treated with A.C.T.H. and corticosteroids.

Authors:  G P Crean; J A Loraine; E T Bell; W I Card; W Sircus
Journal:  Gut       Date:  1966-12       Impact factor: 23.059

3.  Thyroid status and breast cancer. Reappraisal of an old relationship.

Authors:  A R Moossa; D A Evans; A C Brewer
Journal:  Ann R Coll Surg Engl       Date:  1973-09       Impact factor: 1.891

4.  Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.

Authors:  I E Smith; V Macaulay
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

Review 5.  Thyroid disease in relation to breast cancer.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1978-12-01

6.  Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group.

Authors:  R T Chlebowski; R V Smalley; J M Weiner; L E Irwin; A A Bartolucci; J R Bateman
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

7.  HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. I. THE OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER. HORMONE TREATMENT AND POSSIBLE RELATIONSHIP TO CARCINOMA OF THE KIDNEY IN MAN.

Authors:  H J BLOOM; C E DUKES; B C MITCHLEY
Journal:  Br J Cancer       Date:  1963-12       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.